These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29481558)

  • 1. Coverage, social mobilization and challenges of mass Zithromax administration campaign in South and South East zones of Tigray, Northern Ethiopia: A cross sectional study.
    Mulugeta A; Gebregergs GB; Asfaw S; Yemane D; Mitiku M; Meresa B; Gigar G; Kidane A
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006288. PubMed ID: 29481558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage assessment survey following trachoma mass drug administration (MDA) in six districts of Oromia, Western Ethiopia, 2017.
    Bekuma TT; Mosisa Kebebew G; Desalegn Waktole Z; Markos Cafo J; Wirtu D; Gaddisa S
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007924. PubMed ID: 31841516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.
    Tilahun Z; Fenta TG
    BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To eliminate trachoma: Azithromycin mass drug administration coverage and associated factors among adults in Goro district, Southeast Ethiopia.
    Feyisa T; Bekele D; Tura B; Adem A; Nugusu F
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010169. PubMed ID: 35759466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia.
    Ebert CD; Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Ayele Z; Melak B; Chanyalew M; Gashaw B; Tadesse Z; Callahan EK; Jenness SM; Nash SD
    Trop Med Int Health; 2019 Apr; 24(4):493-501. PubMed ID: 30674087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Reported Side Effects following Mass Administration of Azithromycin to Eliminate Trachoma in Amhara, Ethiopia: Results from a Region-Wide Population-Based Survey.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Chanyalew M; Melak B; Ayele Z; Gessese D; Ayenew G; Gashaw B; Tadesse Z; Callahan EK; Nash SD
    Am J Trop Med Hyg; 2019 Mar; 100(3):696-699. PubMed ID: 30675840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of Trachoma in Tigray Region, Northern Ethiopia: Results of 11 Population-Based Prevalence Surveys Completed as Part of the Global Trachoma Mapping Project.
    Sherief ST; Macleod C; Gigar G; Godefay H; Abraha A; Dejene M; Kello AB; Belete A; Assefa Y; Willis R; Chu BK; Solomon AW
    Ophthalmic Epidemiol; 2016; 23(sup1):94-99. PubMed ID: 27918232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and associated factors of active trachoma among 1-9 years old children in Deguatemben, Tigray, Ethiopia, 2018: community cross-sectional study.
    Reda G; Yemane D; Gebreyesus A
    BMC Ophthalmol; 2020 Apr; 20(1):144. PubMed ID: 32293359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trachoma prevalence remains below threshold in five districts after stopping mass drug administration: results of five surveillance surveys within a hyperendemic setting in Amhara, Ethiopia.
    Nash SD; Stewart AEP; Astale T; Sata E; Zerihun M; Gessese D; Melak B; Ayenew G; Ayele Z; Bayissasse B; Chanyalew M; Tadesse Z; Callahan EK
    Trans R Soc Trop Med Hyg; 2018 Dec; 112(12):538-545. PubMed ID: 30265355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coverage evaluation surveys following soil-transmitted helminthiasis and schistosomiasis mass drug administration in Wolaita Zone of Ethiopia-The Geshiyaro project.
    Liyew EF; Chernet M; Belay H; Maddren R; Landeryou T; Kalahasti S; Ower AK; Mekete K; Phillips AE; Anjulo U; Endrias T; Tamiru A; Gidey B; Mehari Z; Mengistu B; Tollera G; Tasew G
    PLoS One; 2021; 16(12):e0260722. PubMed ID: 34932602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of water, sanitation and hygiene interventions on active trachoma in North and South Wollo zones of Amhara Region, Ethiopia: A Quasi-experimental study.
    Tadesse B; Worku A; Kumie A; Yimer SA
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006080. PubMed ID: 29125849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.
    Porco TC; Gebre T; Ayele B; House J; Keenan J; Zhou Z; Hong KC; Stoller N; Ray KJ; Emerson P; Gaynor BD; Lietman TM
    JAMA; 2009 Sep; 302(9):962-8. PubMed ID: 19724043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan.
    Kolaczinski JH; Robinson E; Finn TP
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1362. PubMed ID: 22022632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
    Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel and implications for the elimination of trachoma in ethiopia.
    Shah NA; House J; Lakew T; Alemayehu W; Halfpenny C; Hong KC; Keenan JD; Porco TC; Whitcher JP; Lietman TM; Gaynor BD
    Ophthalmic Epidemiol; 2010 Mar; 17(2):113-7. PubMed ID: 20302432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mass treatment with ivermectin program reach and survey coverage for onchocerciasis elimination in selected endemic areas of Ethiopia.
    Gebrezgabiher G; Yewhalaw D; Hailu A; Mekonnen Z
    PLoS One; 2022; 17(7):e0271518. PubMed ID: 35901026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation-follicular of 5.0-9.9%: Evidence from Malawi.
    Kalua K; Chisambi A; Chinyanya D; Masika M; Bakhtiari A; Willis R; Emerson PM; Solomon AW; Bailey RL
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006543. PubMed ID: 29897902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.